Pharma & Biotech

Breakthrough Phase II Trial Data Reinforces Potential of Survodutide as Leading MASH Treatment

(IN BRIEF) In a significant stride towards combating metabolic dysfunction-associated steatohepatitis (MASH), Boehringer Ingelheim unveils groundbreaking results from a Phase…

1 year ago

Schnelldorf Facility Upgrade: Merck Boosts Life Science Distribution Capacity

(IN BRIEF) Merck, a leading science and technology company, has inaugurated its expanded Life Science distribution center in Schnelldorf, Germany,…

1 year ago

Almirall Launches AK Global Day Campaign to Raise Awareness of Actinic Keratosis and Sun Exposure Risks

(IN BRIEF) Almirall's new data highlights the alarming lack of awareness regarding actinic keratosis (AK), a common precancerous dermatological condition…

1 year ago

Global Study Unveils Barriers to Mental Health Care Access

(IN BRIEF) A recent study commissioned by Boehringer Ingelheim, conducted across eight G20 countries, sheds light on the challenges obstructing…

1 year ago

Roche Announces Retirement of Head of Pharma Partnering and Successor Appointment

(IN BRIEF) Roche (SIX: RO, ROG; OTCQX: RHHBY) reveals the retirement of James Sabry, the Head of Roche Pharma Partnering,…

1 year ago

European Parliament Approves Landmark Pharmaceutical Legislation Reform, Calls for Further Enhancements

(IN BRIEF) The European Parliament has achieved a significant milestone by approving the first reading of extensive reforms to EU…

1 year ago

Boehringer Ingelheim and OSE Immunotherapeutics Forge New Paths in Disease Treatment Collaboration

(IN BRIEF) Boehringer Ingelheim and OSE Immunotherapeutics announce a significant expansion of their partnership, introducing two novel projects to develop…

1 year ago